The FDA uses therapeutic equivalence codes to determine which generic drugs can safely replace brand-name medications. Learn how A and B codes work, why some generics aren't interchangeable, and how pharmacists use the Orange Book to ensure safe substitutions.
A side‑by‑side look at Benicar (Olmesartan) versus other ARBs, covering efficacy, dosing, side effects, cost, and patient‑focused tips.
Not all brand-name drugs have generic versions-even after patents expire. Complex formulations, patent thickets, pay-for-delay deals, and FDA hurdles keep prices high. Here’s why some drugs stay expensive forever.
State laws determine whether pharmacists must or can switch your brand-name prescription to a cheaper generic. These rules affect your costs, safety, and access-and vary widely across the U.S.
An in-depth look into the severe side effects of the antibiotic Zithromax (Z-Pak) and the legal actions against Pfizer Inc. Over-prescription risks, patient reports of severe health issues, and legal options for affected individuals are discussed.
Explore how fibromyalgia and autoimmune disorders intersect, covering shared symptoms, immune mechanisms, diagnosis tips, treatment overlap, and the latest research findings.